Weight Gain and Liver Steatosis in Patients with Inflammatory Bowel Diseases

Weight Gain and Liver Steatosis in Patients with Inflammatory Bowel Diseases

Background and Aim: Most studies focused on the benefits of weight loss on hepatic steatosis and no studies have been specifically designed to assess the role of weight gain on the development of liver steatosis in patients affected by inflammatory bowel diseases. The aim of this study was to analys...

Full description

Bibliographic Details
Main Authors:	Rocco Spagnuolo, Tiziana Montalcini, Daniele De Bonis, Yvelise Ferro, Cristina Cosco, Elisa Mazza, Stefano Romeo, Patrizia Doldo, Arturo Pujia
Format:	Article
Language:	English
Published:	MDPI AG 2019-02-01
Series:	Nutrients
Subjects:	inflammatory bowel diseases weight gain hepatic steatosis transient elastography
Online Access:	https://www.mdpi.com/2072-6643/11/2/303

Similar Items

Clinical and Anamnestic Features of Hepatic Steatosis in Children
by: N.Yu. Zavgorodnia, et al.
Published: (2015-11-01)

Randomized Clinical Trial: Bergamot Citrus and Wild Cardoon Reduce Liver Steatosis and Body Weight in Non-diabetic Individuals Aged Over 50 Years
by: Yvelise Ferro, et al.
Published: (2020-08-01)

Sonological methods for diagnosing liver steatosis and fibrosis in children
by: Yu.M. Stepanov, et al.
Published: (2018-09-01)

The Associations of Anthropometric Parameters and Hepatic Steatosis
by: Maryam Ghandehari, et al.
Published: (2020-03-01)

Protein and vitamin B6 intake are associated with liver steatosis assessed by transient elastography, especially in obese individuals
by: Yvelise Ferro, et al.
Published: (2017-09-01)

Gallbladder Function and Hepatic Structural Changes in Children with Nonalcoholic Fatty Liver Disease
by: N.Yu. Zavgorodnya, et al.
Published: (2016-04-01)

Fibroscan as a non-invasive predictor of hepatic steatosis in women with polycystic ovary syndrome
by: Semanti Chakraborty, et al.
Published: (2020-01-01)

Non-invasive assessment of liver steatosis and fibrosis in HIV/HCV- and HCV- infected patients
by: Valentina Li Vecchi, et al.
Published: (2013-09-01)

Transient Elastography and Controlled Attenuation Parameter (CAP) in the Assessment of Liver Steatosis in Severe Adult Growth Hormone Deficiency
by: Adriana Claudia Lopes Carvalho-Furtado, et al.
Published: (2019-06-01)

Effects of Hepatic Steatosis on Non-Invasive Liver Fibrosis Measurements Between Hepatitis B and Other Etiologies
by: Cheng-Jen Chen, et al.
Published: (2019-05-01)

Diagnosis and quantification of fibrosis, steatosis, and hepatic siderosis through multiparametric magnetic resonance imaging
by: M. Stoopen-Rometti, et al.
Published: (2017-01-01)

Detectability of Liver Steatosis and Fibrosis with Transient Elastography and Controlled Attenuation Parameter in Residents of St. Petersburg
by: V. P. Kovyazina, et al.
Published: (2021-04-01)

Assessment of hepatic fibrosis and steatosis by vibration-controlled transient elastography and controlled attenuation parameter versus non-invasive assessment scores in patients with non-alcoholic fatty liver disease
by: Ahmed M. F. Mansour, et al.
Published: (2020-09-01)

Fatty liver associated with metabolic derangement in patients with chronic kidney disease: A controlled attenuation parameter study
by: Chang-Yun Yoon, et al.
Published: (2017-03-01)

Estimating steatosis and fibrosis
by: Karlas, Thomas, et al.
Published: (2015)

The inverse effect of meal intake on controlled attenuation parameter and liver stiffness as assessed by transient elastography
by: Kanittha Ratchatasettakul, et al.
Published: (2017-04-01)

Prospective Comparison of Transient Elastography Using Two Different Devices: Performance of FibroScan and FibroTouch
by: Serra JT, et al.
Published: (2020-03-01)

Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis
by: Ke Pu, et al.
Published: (2019-04-01)

Noninvasive monitoring of liver fat during treatment with GLP‐1 analogues and SGLT‐2 inhibitors in a real‐world setting
by: Vasiliki Mittag‐Roussou, et al.
Published: (2020-07-01)

Usefulness of Different Imaging Modalities in Evaluation of Patients with Non-Alcoholic Fatty Liver Disease
by: Karolina Grąt, et al.
Published: (2020-08-01)

Noninvasive Assessment of Hepatitis C Virus Infected Patients Using Vibration-Controlled Transient Elastography
by: Mira Florea, et al.
Published: (2021-06-01)

A new non-invasive method for assessing steatosis in chronic liver diseases
by: I G Bakulin, et al.
Published: (2016-02-01)

Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease
by: Abd Hamid, N, et al.
Published: (2018)

The Effects of COVID-19 on the Eating Habits of Children and Adolescents in Italy: A Pilot Survey Study
by: Roberta Pujia, et al.
Published: (2021-07-01)

Ultrasound Elastography in the Assessment of the Intestinal Changes in Inflammatory Bowel Disease—Systematic Review
by: Dominika Ślósarz, et al.
Published: (2021-09-01)

Quantification of Liver Fibrosis, Steatosis, and Viscosity Using Multiparametric Ultrasound in Patients with Non-Alcoholic Liver Disease: A “Real-Life” Cohort Study
by: Alexandru Popa, et al.
Published: (2021-04-01)

What is to be done when transient elastography is not feasible?
by: Raluca Lupusoru, et al.
Published: (2016-12-01)

Liver stiffness in chronic hepatitis C virus infection
by: Mihăilă Romeo-Gabriel
Published: (2019-06-01)

COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey
by: Rocco Spagnuolo, et al.
Published: (2020-08-01)

The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience
by: Yoga Fitriakusumah, et al.
Published: (2019-03-01)

What we need to know when performing and interpreting US elastography
by: So Hyun Park, et al.
Published: (2016-09-01)

Hepatic steatosis in patients with acromegaly
by: Andreani Koutsou‐Tassopoulou, et al.
Published: (2019-10-01)

Effects of a Portfolio-Mediterranean Diet and a Mediterranean Diet with or without a Sterol-Enriched Yogurt in Individuals with Hypercholesterolemia
by: Yvelise Ferro, et al.
Published: (2020-06-01)

Imaging techniques for assessing hepatic fat content in nonalcoholic fatty liver disease
by: Ernesto Roldan-Valadez, et al.
Published: (2008-07-01)

Magnetic resonance‐based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Cyrielle Caussy, et al.
Published: (2020-10-01)

Endoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseases
by: Beichu eGuo, et al.
Published: (2014-07-01)

The usefulness of transient elastography, acoustic-radiation-force impulse elastography, and real-time elastography for the evaluation of liver fibrosis
by: Jong Ho Chung, et al.
Published: (2013-06-01)

Association Between Subclinical Left Ventricular Myocardial Systolic Dysfunction Detected by Strain and Strain‑Rate Imaging and Liver Steatosis and Fibrosis Detected by Elastography and Controlled Attenuation Parameter in Patients with Metabolic Syndrome
by: Vitel A, et al.
Published: (2020-10-01)

Ultrasound-guided transient elastography and two-dimensional shear wave elastography for assessment of liver fibrosis: emphasis on technical success and reliable measurements
by: Jihyuk Lee, et al.
Published: (2021-04-01)

Lipid Oxidation Assessed by Indirect Calorimetry Predicts Metabolic Syndrome and Type 2 Diabetes
by: Arturo Pujia, et al.
Published: (2019-01-01)